Peroxisome proliferator-activated receptor-gamma in normal human pregnancy and miscarriage

Acta Histochemica

Volumn 111, Issue 4, 2009, Pages 373-379

  Toth, Bettina ^a   Bastug, Mehmet ^a   Mylonas, Ioannis ^a   Scholz, Christoph ^a   Makovitzky, Josef ^b   Kunze, Susanne ^a   Thaler, Christian ^a   Friese, Klaus ^a   Jeschke, Udo ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

First trimester; Immunohistochemistry; Miscarriage; Normal pregnancy; Nuclear hormone receptors; Peroxisome proliferator activated receptor gamma

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PLACENTA; PLACENTA VILLUS; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SPONTANEOUS ABORTION; TISSUE DISTRIBUTION; TROPHOBLAST;

EID: 67349150431     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2008.11.020     Document Type: Article

References (50)

1. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4 (1999) 585-595
2. Barak Y., Liao D., He W., Ong E.S., Nelson M.C., Olefsky J.M., et al. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci USA 99 (2002) 303-308
3. Bildirici I., Roh C.R., Schaiff W.T., Lewkowski B.M., Nelson D.M., and Sadovsky Y. The lipid droplet-associated protein adipophilin is expressed in human trophoblasts and is regulated by peroxisomal proliferator-activated receptor-gamma/retinoid X receptor. J Clin Endocrinol Metab 88 (2003) 6056-6062
4. Carrington B., Sacks G., and Regan L. Recurrent miscarriage: pathophysiology and outcome. Curr Opin Obstet Gynecol 17 (2005) 591-597
5. Chinetti G., Fruchart J.C., and Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49 (2000) 497-505
6. Chung P.H., and Yeko T.R. Recurrent miscarriage: causes and management. Hosp Pract (Minneap) 31 (1996) 157-164
7. Daoud G., Amyot M., Rassart E., Masse A., Simoneau L., and Lafond J. ERK1/2 and p38 regulate trophoblasts differentiation in human term placenta. J Physiol 566 (2005) 409-423
8. Demirturk F., Aytan H., Caliskan A.C., Aytan P., and Koseoglu D.R. Effect of peroxisome proliferator-activated receptor-gamma agonist rosiglitazone on the induction of endometriosis in an experimental rat model. J Soc Gynecol Invest 13 (2006) 58-62
9. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20 (1999) 649-688
10. Dubuquoy L., Rousseaux C., Thuru X., Peyrin-Biroulet L., Romano O., Chavatte P., et al. PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut 55 (2006) 1341-1349
11. Dunaif A., Scott D., Finegood D., Quintana B., and Whitcomb R. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 81 (1996) 3299-3306
12. Dunn-Albanese L.R., Ackerman W.E.t., Xie Y., Iams J.D., and Kniss D.A. Reciprocal expression of peroxisome proliferator-activated receptor-gamma and cyclooxygenase-2 in human term parturition. Am J Obstet Gynecol 190 (2004) 809-816
13. Fournier T., Handschuh K., Tsatsaris V., and Evain-Brion D. Involvement of PPARgamma in human trophoblast invasion. Placenta (2007)
14. Fournier T., Tsatsaris V., Handschuh K., and Evain-Brion D. PPARs and the placenta. Placenta 28 (2007) 65-76
15. Glintborg D., Hermann A.P., Andersen M., Hagen C., Beck-Nielsen H., Veldhuis J.D., et al. Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome. Fertil Steril 86 (2006) 385-397
16. Hornung D., Chao V.A., Vigne J.L., Wallwiener D., and Taylor R.N. Thiazolidinedione inhibition of peritoneal inflammation. Gynecol Obstet Invest 55 (2003) 20-24
17. Jiang C., Ting A.T., and Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391 (1998) 82-86
18. Kubota N., Terauchi Y., Miki H., Tamemoto H., Yamauchi T., Komeda K., et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4 (1999) 597-609
19. Lebovic D.I., Kir M., and Casey C.L. Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis. Fertil Steril 82 Suppl 3 (2004) 1008-1013
20. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270 (1995) 12953-12956
21. Lehrke M., and Lazar M.A. The many faces of PPARgamma. Cell 123 (2005) 993-999
22. Li T.C., Makris M., Tomsu M., Tuckerman E., and Laird S. Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update 8 (2002) 463-481
23. Lord J.M., Flight I.H., and Norman R.J. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, d-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev (2003) CD003053
24. Marvin K.W., Eykholt R.L., Keelan J.A., Sato T.A., and Mitchell M.D. The 15-deoxy-delta(12,14)-prostaglandin J(2)receptor, peroxisome proliferator activated receptor-gamma (PPARgamma) is expressed in human gestational tissues and is functionally active in JEG3 choriocarcinoma cells. Placenta 21 (2000) 436-440
25. McIntyre T.M., Pontsler A.V., Silva A.R., St Hilaire A., Xu Y., Hinshaw J.C., et al. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc Natl Acad Sci USA 100 (2003) 131-136
26. Miyazaki Y., Mahankali A., Matsuda M., Glass L., Mahankali S., Ferrannini E., et al. Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone. Diabetes Care 24 (2001) 710-719
27. Nagy L., Tontonoz P., Alvarez J.G., Chen H., and Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93 (1998) 229-240
28. Pavan L., Tarrade A., Hermouet A., Delouis C., Titeux M., Vidaud M., et al. Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process. Carcinogenesis 24 (2003) 1325-1336
29. Rai R., and Regan L. Recurrent miscarriage. Lancet 368 (2006) 601-611
30. Reginato M.J., Bailey S.T., Krakow S.L., Minami C., Ishii S., Tanaka H., et al. A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties. J Biol Chem 273 (1998) 32679-32684
31. Remmele W., and Stegner H.E. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8 (1987) 138-140
32. Ricote M., Huang J.T., Welch J.S., and Glass C.K. The peroxisome proliferator-activated receptor (PPARgamma) as a regulator of monocyte/macrophage function. J Leukocyte Biol 66 (1999) 733-739
33. Rocchi S., Picard F., Vamecq J., Gelman L., Potier N., Zeyer D., et al. A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol Cell 8 (2001) 737-747
34. Rodie V.A., Young A., Jordan F., Sattar N., Greer I.A., and Freeman D.J. Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. J Soc Gynecol Invest 12 (2005) 320-329
35. Schaiff W.T., Carlson M.G., Smith S.D., Levy R., Nelson D.M., and Sadovsky Y. Peroxisome proliferator-activated receptor-gamma modulates differentiation of human trophoblast in a ligand-specific manner. J Clin Endocrinol Metab 85 (2000) 3874-3881
36. Schaiff W.T., Bildirici I., Cheong M., Chern P.L., Nelson D.M., and Sadovsky Y. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor signaling regulate fatty acid uptake by primary human placental trophoblasts. J Clin Endocrinol Metab 90 (2005) 4267-4275
37. Schaiff W.T., Barak Y., and Sadovsky Y. The pleiotropic function of PPAR gamma in the placenta. Mol Cell Endocrinol 249 (2006) 10-15
38. Schild R.L., Schaiff W.T., Carlson M.G., Cronbach E.J., Nelson D.M., and Sadovsky Y. The activity of PPAR gamma in primary human trophoblasts is enhanced by oxidized lipids. J Clin Endocrinol Metab 87 (2002) 1105-1110
39. Schopfer F.J., Lin Y., Baker P.R., Cui T., Garcia-Barrio M., Zhang J., et al. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. Proc Natl Acad Sci USA 102 (2005) 2340-2345
40. Semple R.K., Chatterjee V.K., and O'Rahilly S. PPAR gamma and human metabolic disease. J Clin Invest 116 (2006) 581-589
41. Stephenson M.D., Awartani K.A., and Robinson W.P. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Hum Reprod 17 (2002) 446-451
42. Tarrade A., Lai Kuen R., Malassine A., Tricottet V., Blain P., Vidaud M., et al. Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta. Lab Invest 81 (2001) 1199-1211
43. Tarrade A., Schoonjans K., Guibourdenche J., Bidart J.M., Vidaud M., Auwerx J., et al. PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation. Endocrinology 142 (2001) 4504-4514
44. Tarrade A., Schoonjans K., Pavan L., Auwerx J., Rochette-Egly C., Evain-Brion D., et al. PPARgamma/RXRalpha heterodimers control human trophoblast invasion. J Clin Endocrinol Metab 86 (2001) 5017-5024
45. Tontonoz P., Hu E., and Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79 (1994) 1147-1156
46. Vidal-Puig A., Jimenez-Linan M., Lowell B.B., Hamann A., Hu E., Spiegelman B., et al. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 97 (1996) 2553-2561
47. Vidal-Puig A.J., Considine R.V., Jimenez-Linan M., Werman A., Pories W.J., et al. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99 (1997) 2416-2422
48. Waite L.L., Atwood A.K., and Taylor R.N. Preeclampsia, an implantation disorder. Rev Endocr Metab Disord 3 (2002) 151-158
49. Waite L.L., Louie R.E., and Taylor R.N. Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy. J Clin Endocrinol Metab 90 (2005) 620-626
50. Wang Q., Fujii H., and Knipp G.T. Expression of PPAR and RXR isoforms in the developing rat and human term placentas. Placenta 23 (2002) 661-671